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ABSTRACT  The spike glycoproteins of Semliki Forest virus mediate membrane fusion between 
the viral envelope and cholesterol-containing  target membranes under conditions  of mildly 
acidic pH  (pH <  6.2). The fusion reaction is critical for the infectious cycle, catalyzing virus 
penetration  from  the acidic  endosome compartment.  To define  the role of the viral spike 
glycoproteins  in the fusion reaction, conformational  changes in the spikes at acid pH were 
studied using protease digestion and binding assays to liposomes and nonionic detergent. A 
method was also developed to prepare fragments of both transmembrane subunit glycopoly- 
peptides of the spike, E1 and E2, which  lacked the hydrophobic anchor peptides. Unlike the 
intact spikes the fragments were monomeric  and therefore  useful for obtaining  information 
on conformational  changes in individual  subunits. The results showed that both E1  and E2 
undergo  irreversible  conformational  changes at the  pH  of fusion,  that the conformational 
change of E1 depends, in addition to acidic pH, on the presence of cholesterol, and that no 
major changes in the solubility  properties of the  spikes takes place. On the basis of these 
findings it was concluded  that fusion involves both subunits of the spike and that E1 confers 
the  stereo-specific  sterol  requirement.  The  results indicated,  moreover, that  acid-induced 
fusion of Semliki Forest virus differs in important respects from that of influenza virus, another 
well-defined  model system for protein-mediated  membrane fusion. 
The plasma membrane of a  cell and the membrane of an 
enveloped animal virus form a double barrier that must be 
crossed by the virus genome to initiate replication. A number 
of animal  viruses are  now  known to  use the  constitutive 
endocytic pathway of the cell and membrane fusion as the 
means of passing these membrane barriers and gaining access 
to the cell cytoplasm (reviewed in references 22, 24, 26, and 
43).  This  entry pathway  is  best  characterized for Semliki 
Forest  virus (SFV)',  an  alphavirus.  SFV  binds  to  the cell 
plasma membrane, is internalized in coated vesicles, and fuses 
its membrane with that of the prelysosomal endosome com- 
partment, releasing the nucleocapsid into the cytoplasm. En- 
dosomes have been shown to have a pH range of 5.0-5.5 (11, 
29, 30, 34, 35), and it is the acidic pH that specifically triggers 
the virus fusion reaction. 
Abbreviations used in this paper. DTBP, dimethyl-3,3'-dithiobispro- 
pionimidate; HA, hemagglutinin; MES, 2,(N-morpholino)ethane  sul- 
fonic acid; PMSF, phenylmethylsulfonyl  fluoride; SFV, Semliki For- 
est virus; STI, soybean trypsin inhibitor; TCA, trichloroacetic acid; 
TX 100, Triton X-100; TX114, Triton X-114. 
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SFV fusion can also be triggered in vitro by lowering the 
pH and using cell plasma membranes or artificial liposomes 
as target membranes (36, 40, 41).  Such in vitro studies have 
demonstrated that the fusion reaction is rapid (<10 s), non- 
leaky, has a threshold pH of 6.2, and is strictly dependent on 
the presence of  cholesterol or other 3#-OH sterols in the target 
membrane (21, 40). It is mediated by the virus spike protein, 
a heterotrimer of two transmembrane glycopolypeptides, E 1 
(50,786 mol wt) and E2 (51,855  mol wt),  and a  peripheral 
glycopolypeptide, E3 (I 1,369 mol wt). While all of the struc- 
tural proteins of SFV have been cloned and sequenced (13, 
14), and  the  spike  protein  expressed from  cloned  cDNA 
shown to be fusion-competent (23), the mechanism of fusion 
and the role of the individual components are unknown. 
In  this paper we have characterized the  conformational 
change occurring in the SFV spike at mildly acidic pH by 
monitoring its protease sensitivity and amphiphilic properties. 
It was found that the ectodomains of both E 1 and E2 undergo 
irreversible changes that correlate with the pH of fusion, and 
that the change in El  requires, in addition to acid pH, the 
presence of cholesterol. 
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Virus and Cells:  SFV was propagated from a plaque-purified stock in 
baby hamster kidney  cells as previously  described  (18). Virus labeled  with 
[3H]uridine or [35S]methionine was prepared essentially as before (16, 19). 
Proteinase K Digestion and Fragment Purification:  The ec- 
todomain fragments  of El  and E2 (termed  El* and E2*) were prepared  as 
follows: unlabeled SFV (50 #g protein) and ~ 1 x  l0  ~ clam of 35S-labeled SFV 
were mixed in phosphate-buffered  saline (PBS) containing  calcium and mag- 
nesium at 4°C. Proteinase K (Boehringer-Mannheim  Diagnostics, Inc., Hous- 
ton, TX) and precondensed Triton X-114 (TX114, Fluka A.G., Basel, Switzer- 
land) (3) were added to a final concentration  of 100 zg/ml and 0.5%, respec- 
tively, and the mixture  incubated  on ice for 60 min. The solution  was then 
made 0.5 mM in phenylmcthylsulfonyl fluoride (PMSF), 2% in aprotinin,  and 
1 mg/ml in bovine serum albumin (BSA) (all from Sigma Chemical Co., St. 
Louis, MO) and incubated  l0 min on ice to inactivate protease. TX114  was 
then added to 2%, and the detergent phase pelleted as described (3), but without 
a sucrose cushion; this detergent wash was repeated twice. The resulting aqueous 
phase was added to 0.5 ml packed volume concanavalin  A-Sepharose  (Sigma 
Chemical Co.) that had been prewashed once with basic buffer (130 mM NaC1, 
20 mM Tris pH 7.4,  l  mM CaCl2, and  l  mM MnCl2) and once with basic 
buffer containing  1% aprotinin,  l mg/ml BSA, and 0.5% Triton X-100 (TX 100) 
(buffer l ). After binding at room temperature  for l  h with gentle shaking, the 
mixture was poured into  a  1-ml column and eluted  sequentially with  5 ml 
buffer  1,  5-10 ml buffer 2 (buffer  1 without detergent), 5 ml buffer 3 (basic 
buffer plus 100 zg/ml BSA), and finally 5 ml buffer 4 (buffer 3 plus 500 mM 
a-methyl mannoside). 0.5-ml fractions were collected and l0 zl of  each counted 
in 4 ml Hydrofluor (National Diagnostics, Inc., Somerville, N  J). The glycopro- 
rein peak was pooled and dialyzed overnight vs 20 mM 2,(N-morpholino)ethane 
sulfonic acid (MES)-130 mM NaCl, pH 7 containing  25 zM PMSF. Aliquots 
were then" frozen at -70°C until use. Recovery of 35S-labeled material from the 
column ranged  from 70-100%,  and  1 x  l0  T clam of SFV starting  material 
yielded 1-2 x  lip cpm ofectodomain fragments. 
Pilot experiments  demonstrated  that proteinase  K (PMSF treated) did not 
bind to concanavalin  A. The TXI00 concentrations  of the fractions and final 
dialysate were measured by absorbance at 276 nm. The detergent concentration 
of the dialyzed preparation  was estimated to be <0.001%. 
Immunoprecipitation:  SFV before or after  proteinase  K digestion 
was diluted into Nonidet  P-40 buffer (10 mM Tris pH 7.5, 1% Nonidet  P-40, 
0.15 M NaCl, 2 mM EDTA, and 1 mg/ml BSA). 100-zl aliquots were reacted 
with a rabbit anti-E1  or anti-E2 antiserum (45), or with a nonspecific antiserum 
for 30 min at room temperature.  50 zl of a 10% suspension of fixed S. aureus 
(Zysorbin,  Zymed Labs, San  Francisco,  CA) (vol/vol  in PBS plus  l  mg/ml 
BSA and 0.5% TX 100) was added, and the mixture shaken for 30 min at room 
temperature.  The  Zysorbin  was pelleted,  washed  twice with  Nonidet  P-40 
buffer, once with Nonidet  P-40 buffer containing  0.5 M NaCl, and once with 
water. Samples were resuspended in 30 zl sample buffer containing  SDS, and 
those to be reduced and alkylated were treated as described under gel electro- 
phoresis. 
Cross-linking Experiments:  Thedetergentphaseofundigestedvirus 
or the aqueous phase of proteinase  K-cleaved  virus  was diluted  in 0.15 M 
NaCl.  100-zl aliquots  were  mixed  with  100  zl  freshly prepared  200  mM 
triethanolamine  pH  8.2  containing  2-3  mg/ml dimethyl-3,  3'-dithiobispro- 
pionimidate  (DTBP,  Pierce Chemical  Co.,  Rockford,  IL)  or 0.5-6  mg/ml 
dimethyl suberimidate (Pierce Chemical Co.) (12, 45). Samples were incubated 
1-2 h at room temperature,  precipitated  with trichloroacetic  acid (TCA), the 
precipitates dissolved in sample buffer, and reduced and alkylated as described. 
DTBP samples were dissolved in sample buffer at 37°C to prevent cleaving the 
cross-linker in the nonreduced  samples (38). 
Gel Filtration:  Lectin-purified El* and E2* were sized by chromatog- 
raphy on a 65 x  1.3-cm Sepbadex G-75 column at room temperature.  A 0.25- 
ml sample containing  -6 x  liP clam of 3sS-labeled ectodomains,  100 ~g/ml 
BSA, 25 ;zM PMSF, and l absorbance  unit (605 nm) of blue dextran  in PBS 
without calcium and magnesium was applied to the column.  The sample was 
eluted with PBS without calcium and magnesium containing  100 zg/ml BSA 
and 25 zM PMSF, and 0.5-ml fractions were collected. The blue dextran peak 
was located by measuring absorbance at 605 nm. Radioactivity was determined 
by counting 300-#1 aliquots in 4 ml of Hydrofluor.  100-zl samples of the peak 
fractions  were  TCA-precipitated  and  analyzed  by  gel  electrophoresis  after 
reduction and alkylation. Recovery of radioactivity from the column was 82%, 
of  which 66% eluted in the major peak, from fractions 62-82. The column was 
further calibrated by chromatographing  human gamma globulin (Miles Labo- 
ratories  Inc.,  Naperville,  IL)  and  ovalbumin (Sigma Chemical  Co.)  in PBS 
without calcium and magnesium. Protein elution was monitored by absorbance 
at 280 nm. The void volume determined by human gamma globulin coincided 
exactly with that found by blue dextran. 
Gel  Electrophoresis:  Samples for gel electrophoresis were concen- 
trated  by precipitation  in TCA (10% final concentration),  washed in ice-cold 
acetone  to remove  detergent,  and dissolved in Laemmli  sample  buffer  (2). 
Disulfide bonds were reduced and alkylated as described (27), using concentra- 
tions  of 8  mM  dithiothreitol  and  24  mM  iodoacetamide.  High  and  low 
molecular weight standards (Sigma Chemical Co.) were reduced and alkylated 
before  electrophoresis.  Modified  Laemmli  gels  (2)  were  prepared  with  an 
acrylamide gradient from 7.5 to 15%. Fluorography was performed essentially 
by the method of Chamberlain (5) using 1 M sodium salicylate (pH 7) in 30% 
methanol.  The ~SS-gel bands were cut out using the fluorogram  as a guide; 
radioactivity in individual bands was quantitated  as described (37). 
tiposome  Preparation and  Binding Assays:  Liposomes  for 
binding studies were formed from sterol/phosphatidylethanolamine/pbospba- 
tidylcholine/sphingnmyelin/phosphatidic  acid in the molar ratio  1.5:l:l:l:0.2 
(21, 40), or  -l  cholesterol  per 2  phospholipid  molecules.  Cholesterol  and 
epicholesterol  were  incorporated  as  indicated,  and  liposome  floatation  on 
sucrose gradients  to assay binding  was performed  as described (21). For the 
El* protease-resistance assay, liposomes with an increased sterol concentration 
(3:1:1:1:0.375  molar ratio)  were used,  corresponding  to -1  cholesterol  per 
phospholipid molecule. Lipids were from Sigma Chemical Co. or Avanti Polar- 
Lipids, Inc. (Birmingham, AL). 
Protease  Assays  of  the  Acid-induced  Conformational 
Change:  150-#1  aliquots of  virus containing -  l x  10  ~  cpm [3~S]methionine 
virus and 5 #g viral protein  in MES-saline were adjusted to the indicated pH 
with 0.5 N HCI, incubated  l0 rain at 37°C, neutralized by the addition of 0.5 
N  NaOH,  and  kept  on  ice  until  protease  digestion.  TPCK-trypsin  (Sigma 
Chemical Co.) then was added to a final concentration  of 100 #g/ml in PBS, 
with  1% TXI00 present as indicated.  After incubation  for  l0 min at 0°C or 
37°C, the digestion was stopped by adding a threefold excess of soybean trypsin 
inhibitor  (STI, Sigma Chemical Co.). After  10 min on ice, the samples were 
acid-precipitated and processed for gel electrophoresis as above. 
E2* and El* were similarly digested, except that the samples contained  100 
#g/ml BSA as carrier, and ~ 1.5 x  lip clam of lectin-purified fragments. Some 
of the samples were pH-treated in the presence of cholesterol or epicholesterol 
liposomes at a concentration  of I mM lipid. 
RESULTS 
While the entry pathway of SFV is the best-defined of any 
enveloped animal  virus,  the  fusion  reaction has  not  been 
characterized at the  molecular level.  Our approach to this 
problem was  to expose the  spike glycoproteins of SFV to 
decreasing pH, monitor irreversible changes in their confor- 
mation by biochemical means, and relate these changes to 
the  known properties of SFV fusion. Towards this end,  it 
proved crucial to have water-soluble fragments comprising 
the ectodomains of the two major glycopolypeptide subunits 
of the spike,  El and E2. Such molecules made possible the 
analysis of the individual responses of the subunits to acid. 
Preparation of Soluble Ectodomain Fragments of 
El and E2 
When SFV was solubilized with TX100 and treated with 
proteinase K at 4°C, partial proteolysis of all of the structural 
proteins was observed (Fig.  l). The E 1 glycopolypeptide was 
cleaved within the first l 0 min to a form which in nonreducing 
SDS PAGE gels  migrated slightly  faster than  authentic E 1 
(see arrow). E2 was digested more slowly to a fragment with 
similar  migration  as  the  El-derived fragment.  Concurrent 
with the disappearance of E1 and E2, two distinct low molec- 
ular weight bands appeared (arrow heads). The capsid protein 
(C) was, moreover, rapidly cleaved into two fragments termed 
Cl* and C2", the properties of which will be discussed else- 
where. 
The temperature during the protease digestion was critical; 
while at 4°C, 82% of the viral protein remained TCA-precip- 
itable after 5 min of digestion and 73% after 60 min, the viral 
proteins were all rapidly cleaved to acid-soluble form if the 
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Given the structure and amino acid sequence of the SFV 
spike glycopolypeptides (13),  the  molecular weights  of the 
fragments, and their solubility properties, we concluded that 
E 1" and E2* corresponded to the N-terminal ectodomains of 
E 1 and E2, and that the small peptides were probably derived 
from the transmembrane domains. The molecular weight of 
E 1" (48 kD) indicated that it lacked the entire transmembrane 
anchor of El and possibly an additional 10-15 residues.  The 
presence of [3SS]methionine  in the transmembrane peptide 
first generated by proteinase K suggested that the E 1 cleavage 
site was located N-terminal to the last methionine in position 
402, or at least 12 amino acids from the membrane-spanning 
FiGure  I  Time course of digestion of SFV by proteinase  K. [3sS]- 
Methionine-labeled  SFV was digested with 100/~g/ml proteinase K 
in  0.5%  TXt00  at  4"C.  At  the  indicated  time,  proteinase  was 
inactivated with PMSF  and aprotinin, and samples were then TeA- 
precipitated and resolved  by SDS PAGE under nonreducing con- 
ditions. For the time 0 sample, proteinase  K was pretreated  with 
inhibitors. The ectodomain fragments of El and E2 (arrow) and the 
presumed  transmembrane  domains  (arrowheads)  are  indicated. 
Capsid protein is cleaved within the first 5 rain of digestion to two 
fragments termed CI* and C2". 
temperature was elevated to 37"C. The partial cleavages were 
not specific to proteinase K; similar digestion patterns resulted 
using either subtilysin or pronase. The detergent TX 100 could 
be replaced with TX 114 or octylglucoside without changes in 
digestion pattern. 
The co-migrating E 1- and E2-derived fragments could be 
separated from each other on SDS polyacrylamide  gels simply 
by reducing the samples before electrophoresls (Fig. 2 B, com- 
pare lanes 1 and 2). Two distinct bands were then seen with 
apparent molecular weights of 48  kD and 41  kD (arrows). 
The substantial decrease in electrophoretic mobility of  the 48- 
kD  fragment  band  after  reduction  was  consistent  with  a 
similar change in  intact El  which allows the separation of 
nonreduced E1 from E2 although they have similar molecular 
weights  (-51  kD and  52 kD,  respectively) and migrate to- 
gether after reduction (reference 45; Fig. 2A, compare lanes 
1 and 2). The observation that the 48-kD fragment appeared 
early during digestion with proteinase K suggested that it was, 
indeed, derived from El.  Conversely, the 41-kD band  ap- 
peared in concert with the digestion of E2. These assignments 
were confirmed by immunoprecipitation with antibodies spe- 
cific for E1  or E2 (Fig.  3). The 48-kD fragment was conse- 
quently named El* and the 41 kD fragment E2*. The small 
molecular  weight  fragments  were  not  precipitated  by  the 
antibodies and could not be positively identified. 
The water-soluble nature of E 1" and E2* was demonstrated 
using TX 114 partitioning, a method that allows the separation 
of amphiphilic and soluble proteins on the basis of detergent 
binding (3). Nondigested E1  and E2 and the small peptides 
generated  during  proteolyis partitioned  into  the  detergent 
phase  (Fig.  2B,  lane  3).  In  contrast,  El*  and  E2*  were 
recovered in the aqueous phase (Fig. 2 B, lane 4), indicating 
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FIGURE 2  The electrophoretic mobility and solubility properties of 
the E1  and E2 ectodomains.  (A) Intact viral proteins were electro- 
phoresed  either without (lane  1)  or with  (lane 2)  reduction and 
alkylation.  E1  and  E2  co-migrate after  reduction.  (B)  A  60-min 
proteinase  K digest of virus  in TXl14 was electrophoresed either 
without (lane  1) or with (lanes 2-4) reduction and alkylation. The 
complete digestion mixture is shown in lanes I and 2. After TX114- 
partitioning, the detergent phase (lane 3) was overloaded to dem- 
onstrate  the partitioning of putative transmembrane  domains (ar- 
rowhead) and nondigested  E1 and E2. The aqueous phase (lane 4) 
contained the ectodomains (arrows) and capsid fragments. 
FIGURE 3  Immunoprecipitation of El* and  E2* with specific anti- 
bodies. Nondigested SFV (panel A) or SFV digested with proteinase 
K for 60  min  (panel  B) were either TeA-precipitated (lane  I)  or 
immunoprecipitated with an anti-El  (lane 2), anti-E2 (lane 3),  or 
nonspecific  rabbit antiserum  (lane  4).  Immune complexes were 
absorbed to S.  aureus  and processed for gel electrophoresis.  Sam- 
pies in A  were electrophoresed without reduction; samples in  B 
were reduced and alkylated. segment.  E2*  probably  lacked  both  the  C-terminal  polar 
domain (31  residues) of E2  and the transmembrane region 
that contains two methionine residues. Judging from its ap- 
parent molecular weight of 41 kD, it too may have lost ~ 10- 
15 residues from the extramembraneous side. 
Purification  of E1 * and E2* 
After proteinase K  digestion, El* and E2* were present in 
a mixture of protein fragments, protease, detergent, and pro- 
tease inhibitors. To purify the ectodomains, the aqueous phase 
generated by TX 114 partitioning (see above) was reacted with 
concanavalin  A-Sepharose which  binds  intact  E1  and  E2 
(28).  The  affinity column  was  first eluted  with  detergent- 
containing buffer to ensure complete removal of capsid frag- 
ments and protease. After extensive washing to remove deter- 
gent, a glycoprotein fraction was eluted in buffer containing 
a-methyl mannoside (Fig.  4).  In addition  to  El* and  E2*, 
which constituted the major components, this fraction con- 
mined variable amounts of a 56-kD band. It may correspond 
to the anchor-free fragment of the p62 precursor glycoprotein, 
which  was sometimes present in  our virus preparations. In 
addition,  the  glycoprotein  peak  occasionally  contained 
smaller peptide fragments that we assume to be derived from 
further proteolysis of E1 and E2. 
El *  and E2* Are Monomers 
Chemical cross-linking and gel filtration were next used to 
determine whether  El*  and  E2*  remained  associated with 
each other or occurred as monomers in solution. In the intact 
virus, E1  and E2 are present as heterodimers, which can be 
cross-linked to a  100-kD protein with dimethyl suberimidate 
(12)  or  DTBP  (45),  and  react  with  cross-linker even after 
solubilization  in  nonionic detergent (45).  We used both of 
these cross-linkers on TX 114-solubilized and phase-separated 
viral  spikes  and  proteinase  K  fragments.  Fig.  5  shows  an 
experiment with  DTBP,  a  cross-linker that  is  cleavable by 
reduction.  In addition to the monomer bands of E1 and E2, 
a  100-kD band was seen after cross-linking (compare lanes 1 
and  2)  which  was lost when  the  sample was reduced with 
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FIGURE  4  Affinity purification of El* and E2* on concanavalin A- 
Sepharose.  SFV was digested with proteinase K and the ectodo- 
mains separated from noncleaved E1  and  E2 and transmembrane 
domains by TX114 partitioning. This aqueous phase was bound to 
concanavalin A-Sepharose and  sequentially eluted  with  TXl00- 
containing buffer,  buffer alone, and  buffer  containing 0.5  M  a- 
methyl mannoside. [3SS]Methionine-labeled  viral protein was mon- 
itored by liquid scintillation counting of an aliquot of each fraction, 
and TX100 by absorbance at 276 nm. 
FIGURE  5  Reaction  of El/E2 and EI*/E2*  with DTBP, a cleavable 
cross-linker.  Triton X114 partitioning was used to separate  E1  and 
E2 from untreated virus and El* and F2* from proteinase K-digested 
virus.  Part of each sample was reacted with DTBP,  as indicated for 
1 h at room temperature. Samples were then TCA:precipitated and 
processed for gel electrophoresis without reduction. 
"dithiothreitol  (data  not  shown).  In  contrast,  El*  and  E2* 
showed virtually no cross-linked species when  reacted with 
DTBP under the same conditions" (lanes 3 and 4), suggesting 
that unlike El  and E2, El* and E2* were present mainly as 
monomers. Cross-linking with  dimethyl  suberimidate gave 
the same result. 
Gel filtration studies were also consistent with the mono- 
meric nature of E 1" and E2*. When lectin-purified, radiola- 
beled E 1" and E2* were passed over a Sephadex G-75 column, 
most of the  radioactivity eluted  as  a  broad  peak centered 
around the position of ovalbumin (~45 kD) (Fig.  6). Given 
the  apparent  molecular  weights  of El*  and  E2*  on  SDS 
PAGE,  this was the  position  expected of monomeric frag- 
ments. Dimers or higher oligomers of the ectodomains would 
have eluted in  the void volume of the column (see elution 
profile of blue dextran, Fig. 6). SDS PAGE and fluorography 
of the fractions showed that the peak observed in  fractions 
50-61 consisted mainly of the 56-kD contaminant, the main 
peak  (fractions  62-82)  of El*  and  E2*,  and  the  trailing 
material (fractions 82-100) of E 1" and E2* with some smaller 
fragments. 
KIELIAN  AND  HELENIUS 
Acid-induced Changes in Hydrophobicity of E2* 
The water-soluble ectodomain of the influenza virus fusion 
protein (a 208-kD bromelain fragment of the hemagglutinin 
molecule; 4)  is  known  to  undergo  a  major conformational 
change at acidic pH.  It exposes a  new hydrophobic moiety 
that renders the fragment amphiphilic and able to bind deter- 
gent, lipid, or another bromelain fragment of hemagglutinin 
(8,  33).  The  change  correlates with  fusion  activity  and  is 
thought to reflect the analogous interaction between the spike 
glycoprotein and the target membrane during fusion (8,  33, 
43).  To determine whether a  similar change occurs in  El* 
and/or  E2*,  their  partitioning  was  determined  in  TXII4 
buffered to different pHs. As shown in Fig. 7, it was observed 
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FIGURE  6  Gel filtration of El* and E2*. Lectin-purified El* and E2* 
were chromatographed on a Sephadex G-75 column in PBS con- 
taining  BSA  and  25  /~M  PMSF. The  elution  of  3ss-labeled  virus 
protein was determined by  liquid scintillation counting, and  the 
elution of tracer blue dextran in the same column run was deter- 
mined by absorbance at 605  nm.  In a separate  column run, the 
elution of ovalbumin was determined by absorbance at 280 nm. 
FIGURE  7  The pH dependence of ectodomain fragment partition- 
ing in TX114. SFV was digested with proteinase K for 30 min on ice 
and  protease  inhibitors  added.  The  mixture  was  partitioned in 
TX114  to  separate  the  aqueous  phase  containing  El*  and  E2*. 
Aliquots of the aqueous phase were adjusted to 1% TX114, treated 
at  the  indicated pH  for  10  min  at  37°C,  and  separated into  a 
detergent pellet  and aqueous supernatant by centrifugation through 
a sucrose cushion at the indicated pH. Samples were electropho- 
resed after reduction and alkylation. For each pH, the left lane is 
the detergent pellet and right lane the aqueous supernatant. Parti- 
tioning was similar if performed after neutralization. 
Changes in Protease Sensitivity of E  1 and E2 
To obtain evidence for a relevant acid-induced conforma- 
tional change, we turned to the  intact viral protein.  Using 
trypsin and  other proteolytic enzymes, we hoped to detect 
altered exposure of sites for protease cleavage in viral spikes 
after treatment at acid pH. All digestions were performed at 
neutral pH, and thus were expected to reflect only irreversible 
changes. 
Virus particles labeled with  [sSS]methionine  were treated 
with buffers of varying pH, neutralized, digested with trypsin, 
and subjected to SDS PAGE without reduction.  The diges- 
tions  were  performed  either at  37  ° or  at  4°C,  and  in  the 
presence or absence of TX100.  When the trypsin digestion 
was performed at 4°C in TX100, it was found that prior acid 
treatment made E2 totally trypsin sensitive with a pH thresh- 
old around pH 6.2 (Fig. 8). El, on the other hand, remained 
relatively resistant to trypsin under these digestion conditions, 
being reduced only by ~25%  after pH 5 treatment. Similar 
effects on E2 were observed when TXI00 was omitted (not 
shown), in agreement with the previous finding of Edwards 
et al. (9) that E2 in the closely related Sindbis virus becomes 
trypsin sensitive after low pH treatment. 
When  trypsin  digestion  was  performed  at  37°C  in  the 
presence  of TXI00,  a  totally  different  pattern  of protease 
sensitivity emerged (Fig.  8).  Irrespective of prior pH treat- 
ment, E2 was totally trypsin sensitive. In contrast, while fully 
digested in  its pH  7  form,  E 1 was converted to  a  trypsin- 
resistant form with a pH threshold of -  6.2.  About 30% of 
the total E1  was converted by a  10-min pH  5 treatment at 
37°C. 
Acid  treatment  thus  caused  a  change  in  the  SFV  spike 
glycoprotein, which modified the trypsin sensitivity of both 
E1  and  E2.  Similar results were obtained using either chy- 
motrypsin  or  pronase,  suggesting  that  a  rather  extensive 
change in  spike structure  may have occurred.  Importantly, 
the pH dependence of the changes in both El  and E2 corre- 
sponded closely to the pH dependence of SFV fusion, having 
a midpoint at -pH 6.0.  The kinetics of the conversion were 
also similar to the known rate of fusion. To determine this, 
that a significant fraction of E2* partitioned into the detergent 
phase at pH 5.6 or lower, while El* remained in the aqueous 
phase from pH 7.0 to pH 5.0. Binding to liposomes (prepared 
from  cholesterol/phosphatidylethanolamine/phosphatidyl- 
choline/sphingomyelin/phosphatidic acid,  1.5:1:1:1:0.2)  was 
assayed by incubating liposomes together with lectin-purified 
El* and E2* at pH 5.0 or 7.0.  Liposomes were then isolated 
from unbound protein by floatation on sucrose gradients (21). 
No significant association of  either fragment could be detected 
by this technique,  nor did the exposure of the fragments to 
liposomes at different pH modify their subsequent partition- 
ing in TX114. 
Taken together the results indicated that El* did not be- 
come amphiphilic when exposed to acid. In contrast, E2* did 
seem to become rather more hydrophobic, but the  change 
was  not  as  clear-cut  and  complete  as  that  observed  with 
influenza bromelain fragment of hemagglutinin.  It also oc- 
curred  at  a  pH  of 0.6  units  below the  threshold  for SFV 
fusion,  which  is  pH  6.2.  It thus  seemed doubtful  that  the 
change in E2* was directly involved in the fusion activity of 
the spikes. 
FIGURE  8  Trypsin sensitivity of viral proteins after low pH treat- 
ment. Aliquots of intact virus in MES-saline buffer were treated at 
the indicated pH for 10 min at 37°C, neutralized, and then digested 
with 100 pg/ml trypsin in 1% TX100 for 10 min at 0°C or 37°C. The 
reaction was terminated by the addition of STI  and the samples 
processed  for gel electrophoresis without reduction. Control lane 
at left shows virus reacted with premixed trypsin and STI. 
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tralization  and  trypsin digestion.  Digestion  was  performed 
either at 0*C or 37"C in the presence of TXI00, the samples 
subjected to SDS PAGE, and the ass present in the E 1 and 
E2 bands directly quantitated after fluorography. The conver- 
sion in each case was virtually complete after 10 s of acidifi- 
cation.  We  have  previously  shown  that  SFV  fusion  takes 
10-15  s  (41).  It appeared that  the  irreversible conforma- 
tional changes detected by protease sensitivity reflected the 
fusion activity of the protein. 
Changes in Protease Sensitivity of El* and E2* 
The changes in the protease sensitivity of E1  and E2 did 
not  necessarily mean  that  both  underwent  conformational 
changes at acidic pH.  It was possible that  a  change in  one 
polypeptide could  lead  to  altered  accessibility of the  other 
polypeptide within  the  dimeric complex.  By exposing El* 
and E2* to low pH and then determining their trypsin sensi- 
tivity at 4* and 37"C, it was possible to assay the pH-induced 
changes of the individual polypeptides in solution. 
When trypsinization was performed at 4"C,  no change in 
E l* was seen irrespective of pH treatment, thus conforming 
with the behavior of intact E 1 (Fig.  9). Although in general 
somewhat more  sensitive to  trypsin,  E2*  resembled E2  in 
showing a clear-cut increase in sensitivity below pH 6.2 (Fig. 
9). The digestion patterns of El* and E2* were not affected 
by the presence of nonionic detergent. Interestingly, we found 
that the 56-kD fragment, which we assume to be derived from 
the p62 precursor of E2 and E3, proved sensitive to trypsin 
at all  pH  values tested.  This result agrees with the  trypsin 
sensitivity of metabolically labeled  p62  as  assayed  in  cell 
lysates (Wagner,  K.,  A.  Helenius,  and  M.  Kielian,  unpub- 
lished results). 
When  trypsinization  was  performed  at  37"C,  the  initial 
results suggested a difference between the fragment E l* and 
FIGURE 10  Trypsin  resist- 
ance of El* acidified in the 
presence  of  cholesterol- 
containing liposomes. Lec- 
tin-purified  El*  and  E2* 
were diluted in MES-saline 
buffer to a final concentra- 
tion of 100 #g/ml BSA and 
1 mM  lipid as either cho- 
lesterol (~-OH) or epicho- 
lesterol (~-OH) containing 
liposomes.  Samples  were 
pH-treated  10  min  at 
37"C,  neutralized,  and 
then  digested for  10  min 
with trypsin at 37"C in the 
absence  of detergent. Re- 
duced and alkylated sam- 
ples were then analyzed by 
SDS PAGE. Control lane at 
left  shows  ectodomains 
treated  with  premixed 
trypsin/STl. 
intact El. Both E2* and El* were completely cleaved at 37"C, 
regardless of prior pH treatment. No trypsin-resistant E 1" was 
observed. One difference between the experiments, however, 
was the presence or absence of membranes. The pH treatment 
of the lectin-purified fragments was therefore repeated in the 
presence  of  cholesterol  or  epicholesterol-containing  lipo- 
somes. The change to trypsin resistance could now be repro- 
duced with the El* fragment (Fig.  10, lanes 4 and 5), and it 
proved absolutely dependent on the presence of cholesterol. 
The  fusion-inactive epimer,  epicholesterol,  was inactive  in 
promoting this conformational change (Fig.  10, lanes 2 and 
3).  Further  studies  showed  that  the  cholesterol  had  to  be 
present in a lipid membrane; it had no activity if added alone 
in aqueous buffer or dispersed in TX100 (not shown). The 
limited aqueous  solubility of cholesterol (15) may have af- 
fected these results. After pH treatment, the trypsin digestion 
could be performed in the presence of TX 100 without chang- 
ing the outcome. 
The  conformational  change  in  El*  detected  by  trypsin 
digestion was thus found to depend both on exposure to a pH 
_< 6.2 and on the presence of cholesterol. The results implied 
that there is a stereospecific interaction with cholesterol, which 
may explain the requirement for 3~-OH sterols observed in 
SFV fusion. 
The virus membrane is known to contain cholesterol de- 
rived from the plasma membrane of the host animal cell (25). 
It  is  thus  possible  that  the  virus  itself was  the  source  of 
cholesterol in the conversion of intact E 1 (Fig. 8). The limited 
availability of sterol may explain the finding that not all of 
the viral E 1 was detected as trypsin-resistant. 
DISCUSSION 
FiGUrE  9  Trypsin sensitivity of isolated El* and E2* after pH treat- 
ment. Lectin-purified El* and E2* were diluted in MES-saline buffer, 
treated at the indicated pH for  10 rain at 37°C,  neutralized, and 
digested with  trypsin  at  0*C  in  I%  TXI00.  Samples  were  then 
processed as in  Fig. 8, and reduced and alkylated. Control lane at 
right shows ectodomains treated with premixed trypsin/STl. 
The  fusion  activity of animal  viruses  depends  on  specific 
virally encoded  membrane proteins.  The  proteins must be 
integrated into a bilayer membrane in order to be active, but 
no other viral components are needed (10,  23,  32, 42).  The 
influenza hemagglutinin (HA), which is the best characterized 
of the fusion factors, undergoes a  conformational change at 
acidic pH which exposes a previously concealed hydrophobic 
domain  of the  trimeric spike glycoprotein. Several lines of 
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conserved N-terminal sequences of the HA2 subunits (7,  8, 
33).  It is likely that this hydrophobic moiety binds to the 
target membrane, and thus facilitates the close approach of 
the two membranes (7, 8, 33, 43). 
Although unrelated to amino acid sequence, size, and over- 
all structure, the SFV spike glycoprotein is similar to HA in 
its general activities. It binds the virus to cell surface receptors, 
it  causes  efficient  acid-activated  membrane  fusion,  and  it 
contains the neutralizing antigenic epitopes (reviewed in ref-" 
erence 22).  SFV-induced fusion occurs, however, at a some- 
what higher pH than  influenza,  it is more rapid,  and  it is 
absolutely dependent on the presence of cholesterol or other 
3f3-OH containing sterols in the target membrane (21,  40). 
Unlike HA, the spike protein of SFV does not have distinct 
hydrophobic peptide sequences located outside of the trans- 
membrane regions (6, 31). E 1 does, however, contain a highly 
conserved internal uncharged stretch of 17 residues that has 
been suggested to play a role in fusion (6,  13, 31). 
The results reported here indicate that, like HA, the SFV 
spike glycoprotein undergoes conformational changes at the 
pH of fusion. Irreversible alterations were detected in both of 
the major subunits of the spike, E1  and E2. The changes in 
E2 render it more sensitive to digestion by trypsin and other 
proteolytic enzymes, as recently reported for the E2  of the 
related  Sindbis  virus  (9).  E1  becomes,  in  contrast,  more 
resistant to trypsin, and this change appears to depend both 
on  exposure  to  acid  and  on  the  presence  of cholesterol. 
Apparently one or more critical cleavage sites needed for full 
degradation are masked in the low pH form by a mechanism 
that  depends  on  a  molecular interaction  between  El  and 
cholesterol. 
The changes in  El  and  E2  correlate quite  well with  the 
known properties of SFV  fusion  (pH-dependence, kinetics, 
and sterol requirement), and thus probably reflect the altera- 
tion in the protein that makes it fusion active in vitro. There 
are, moreover, indications that the alterations in E 1 and E2 
are relevant to SFV entry into cells. We have shown that El's 
conversion to trypsin resistance occurs in baby hamster kid- 
ney cells during endocytic uptake and infection, and that. it is 
blocked by monensin, an entry inhibitor that elevates the pH 
in endosomes (17;  Kielian, M., M. Marsh, and A. Helenius, 
manuscript in preparation). To detect the corresponding con- 
version of intracellular E2 has proven more difficult because 
of its sensitivity to cellular proteases even at neutral pH. The 
evidence to date for the biological relevance of the E2 con- 
version has been obtained using fus-1,  an SFV mutant that 
requires a lower pH for fusion than wild type SFV (20). When 
we assayed E2's trypsin sensitivity in fus-1, we observed that 
the  pH  threshold  of the  conformational  change  was  also 
shifted to a  more acidic value (Kielian, M., M. Marsh, and 
A. Helenius, manuscript in preparation). 
The acid-induced changes in the SFV spike glycoproteins 
differed in important respects from those observed for influ- 
enza  HA.  We  found  no  convincing evidence from studies 
with  El*  and  E2*  for  the  exposure  of new  hydrophobic 
moieties that would allow the SFV spike to bind to the target 
membrane in a nonspecific hydrophobic manner. Instead of 
HA-like nonspecific insertion,  SFV fusion may, in fact, de- 
pend on a stereospecific protein interaction with cholesterol. 
The differences between influenza and SFV fusion illustrated 
by  the  results  show  that,  in  considering  viral  membrane 
fusion,  one should  not think  in  terms of a  single  unifying 
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mechanism. The fusion proteins identified so far in various 
enveloped viruses are diverse in general structure and amino 
acid sequence, and thus may function according to a variety 
of principles that can be determined only by molecular anal- 
ysis of the individual systems. 
One of the reasons why the HA of influenza is relatively 
well understood compared with other virus spike glycopro- 
teins is the availability of the isolated ectodomain. The bro- 
melain  HA  fragment has  allowed  detailed  functional  and 
structural  studies that would be impossible with the  intact 
amphiphilic protein (8, 33, 44).  We have shown here that it 
is  feasible to derive the  corresponding soluble ectodomain 
fragments from SFV  spikes, and  that they can be used  to 
characterize the functional properties of the spike. After nu- 
merous attempts at making such fragments, the critical pa- 
rameters that allowed cleavage of both major transmembrane 
subunits  at  a  site  close  to  the  membrane without  further 
cleavage of the ectodomain were found to be low temperature 
and the presence of solubilizing concentrations of nonionic 
detergent during digestion.  While the ability of the ectodo- 
main fragments to undergo conformational changes at low 
pH appeared to be retained, the intermolecular association 
between E1  and E2 was not. Their monomeric nature sug- 
gested that the interactions between E1  and E2 in the intact 
spike are concentrated in or near the transmembrane domain. 
Our results suggest,  moreover, that the conformation of the 
ectodomains is largely independent of the membrane anchor- 
ing segments, and that cleavage may preferentially occur at 
the interphase between the transmembrane domain and the 
ectodomain.  The  soluble  ectodomain  fragments contained 
the  oligosaccharide chains,  which  enabled their binding to 
concanavalin A, while the C-terminal hydrophobic peptides 
of both E 1 and E2 appeared to contain the fatty acyl groups 
(Wagner, K., A. Helenius, and M.  Kielian, unpublished re- 
sults;  see also reference 1). The fate of the third component 
of the spike, E3, was difficult to visualize on our gels owing 
to its weak labeling with  pS]-methionine (cf.  Fig.  1).  It is 
unlikely, however, that E3 plays a critical role in membrane 
fusion because it is not found in the closely related Sindbis 
virus (39). 
The results reported here raise challenging issues in under- 
standing  the  significance of cholesterol in  SFV  fusion.  Al- 
though optimal fusion requires as much as 1 cholesterol per 
2  phospholipids,  the  sterol structural  requirements  do  not 
appear to correlate with known effects of sterol on phospho- 
lipid condensation or membrane phase transition (2 I). Yet, 
cholesterol appears active in promoting the conformational 
change in El* only when presented within the context of a 
lipid bilayer. Furthermore, if El* has a stereospecific choles- 
terol binding site, the sterol must be removed from the bilayer 
after binding,  as El* does not remain liposome-associated. 
Future studies must address the molecular nature of  the sterol- 
E1  interaction,  and the  possible role of the  conserved un- 
charged sequence in E 1. It cannot be ruled out that both E1 
and E2 are required in concert to mediate stable membrane 
binding, and thus the possible cooperative inter~fction of the 
dimer with membranes must be investigated. Finally, it will 
be important to determine if  cholesterol is really a prerequisite 
for entry during an in vivo infection. If so, it is conceivable 
that  this  requirement  might be exploited  in  the  design  of 
specific antiviral agents against toga- and  other cholesterol 
requiring viruses. We thank Mark Marsh and Judy White for helpful discussion, Susan 
Froshauer  for reading the  manuscript,  Anne Beidler for assistance 
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are especially grateful to Leah D'Eugenio, Barabara Longobardi, and 
M. Lynne Wootton for preparing the manuscript. 
This work was supported by a grant from the National Institutes 
of Health (AI 18599) to A. Helenius and a Swebilius  Cancer Research 
Award to M. Kielian. 
Received  for publication  13 June 1985. 
REFERENCES 
I.  Berger, M., and M.  F. G. Sehmidt.  1984. Identification  of acyl donors and acceptor 
proteins for fatty acid acylation in BHK celts infected with Semliki Forest virus. EMBO 
(Eur.  Mol. BioL  Organ.)J.  3:713-719. 
2.  Blobel, G.,and B. Dobberstein.  1975.Transfer ofpruteinsaerossmembranes. I, Preseoce 
of proteolytically  processed  and unprocessed nascent immunoglobulin light chains on 
membrane-bound ribosomes of routine myeloma..L Cell Biol. 67:835-851. 
3.  Bordier,  C.  1981. Phase separation of integral  membrane proteins in Triton X-114 
solution.  J. Biol.  Chem. 256:1604-1607. 
4.  Brand,  D., and J. Skehel.  1972. Crystalline  antigen from the influenza virus envelope. 
Nature New Biol. 238:145-147. 
5.  Chamberlain, J. P. 1979. Fluorographic detection of radioactivity in polyacrylamide  gels 
with the water-soluble  floor, sodium salicylate. Anal Biochem.  98:132-135. 
6.  Dalgarno,' L.,  C.  Rice,  and J.  Strauss.  1983. Ross River virus 26S  RNA: complete 
nucleotide sequence and deduced sequence of  the encoded structural proteins.  Virology. 
129:170-I87." 
7.  Daniels,  R. S., J. C. Downie, A. J. Hay, M. Knossow, J. J. Skehel, M. L. Wang, and D. 
C. Wiley.  1985. Fusion mutants of the influenza haemagglutinin. Cell. 40:431-439. 
8.  Doms, R.  W.,  A. Helenius, and J.  White.  1985.  Membrane fusion activity of the 
influenza hemaggfutinin: the low pH-induced eonformational change. J. Biol.  Chem. 
260:2973-2981. 
9.  Edwards, J., E. Mann, and D. T. Brown. 1983. Conformational changes in Sindbis virus 
envelope proteins accompanying exposure to low pH. J.  Virol. 45:1090-1097. 
10.  Florkiewicz,  R.,  and J.  Rose.  1984.  A cell  line expressing  vesicular stomatitis virus 
glyeoprotein fuses at low pH. Science ( Wash. DC). 225:721-723. 
1 I. Galloway, C. J., G. E. Dean, M. Marsh, G. Rudniek, and L Mellman. 1983. Acidification 
of macrophage and fibroblast  endocytic vesicles in  vitro.  Proc.  Natl.  Acad.  Sci.  USA. 
80:3334-3338. 
12.  Garoff, H., and K. Simons. 1974. Location of the spike glycoproteins  in the Semliki 
Forest virus membrane. Prc~. Natl. Acad.  Sci.  USA. 71:3988-3992. 
13.  Garuff, H., A.-M. Frisehauf,  K. Simoos, H. Lehrach, and H. Dclius.  1980. Nucleotide 
sequence of eDNA coding for Semliki  Forest virus membrane glycoproteins.  Nature 
(Lond.). 288:236-241. 
14. Garoff, H., A.-aM. Frischauf,  K. Simons, H. Lehrach, and H. Delius.  1980. The capsid 
protein of Semliki  Forest  virus has clusters  of basic  amino acids and prolines  in its 
amino-terminal rw,  ion. Proc. Natl.  Acad.  Sci.  USA. 77:6376-6380. 
15.  Haberland, M. E., and J. A. Reynolds.  1973. Self-association  of eholesterul  in aqueous 
solution.  Proc. Natl.  Acad.  Sci.  USA.  70:2313-2316. 
16.  Hetenius, A., J. Kartenbeck, K. Simons, and E. Fries.  1980. On the entry of Semliki 
Forest virus into BHK-21  cells. J. Cell Biol.  84:404-420. 
17.  Helenius, A., M.  Kiehan, J. Weltsteed,  I. Mellman, and G. Rudnick.  1985. Effects of 
monovalent cations on Semliki  Forest virus entry into BHK-21 cells. J. Biol.  Chem. 
260:5691-5697. 
t8.  K~riginen, L., K. Simons, and C. H. yon Bonsdorff.  1969. Studies of Semliki  Forest 
virus subviral components. Ann. Med. Exp. BioL Fenn. 47:235-248. 
19.  K~ri~iinen, L., aod H. Soderlund.  197 I. Properties of  Semliki Forest virus nueleocapsid. 
1. Sensitivity  to paoereatie ribonuclease.  Virology. 43:291-299. 
20. Kielian,  M., S. Ke~nen, L. ICi~inen, and A. Helenius. 1984.  Membrane fusion 
mutants  of  Semliki  Forest  virus.  J. Cell  Biol.  98:139-145. 
21. Kielian,  M. C.,  and A. Helenius.  1984.  Role of  cholesterol  in fusion  of  Semliki  Forest 
virus with membranes. J. ViroL 52:281-283. 
22.  Kielian,  M. C., and A. Helenius.  1985. Entry of alphaviruses.  In The Viruses Series. H. 
Fraenkel-Conrad  and R. Wagner, editors.  Plenum Publishing  Cot0,  New York. In 
press. 
23.  Kondor-Koch, C., B. Burke,  and H. Garoff. 1983. Expression  of Semliki  Forest virus 
proleins from cloned eDNA. I. The fusion  activity of the spike  glycoprotein.  J.  Cell 
Biol. 97:644-651. 
24.  I-eoard, J., and D. Miller.  1982. Uneoating of enveloped viruses. Cell. 28:5-6. 
25.  Luukkonen, A., C.-H. von Bonsdorff,  and O. Renkonen.  1977. Characterization of 
Semliki Forest virus grown in mosquito cells. Comparison with the virus from hamster 
cells.  Virology. 78:331-335. 
26.  Marsh, M.  1984. The entry of enveloped viruses into cells by endoeytosis.  Biochem.  J. 
218:1-10. 
27.  Marlin,  K. S.,  and  K.  Simon,s.  1983.  Reduced temperature prevents transfer of a 
membrane 81yeoprotein to the cell surface but does not prevent terminal glycosylation. 
Cell.  34:233-243. 
28.  Mattila,  K.  1979. Separation  of the integral  membrane glycoproteins  El  and E2  of 
Semliki Forest virus by affinity chromatography on concanavalin A-sepharose. Biochim. 
Biophys.  Acta.  579:62-72. 
29.  Merion, M., and W. S. Sly.  1983. The role of intermediate vesicles in the adsorptive 
endocytosis  and transport of ligand to lyosomes by human fibroblasts.  J.  Cell Biol. 
96:644-650. 
30.  Murphy, R. F., S. Powers, and C. R. Cantor.  1984. Endosome pH measured in single 
cells by dual fluorescence  flow cytometry: rapid acidification  of insulin  to pH 6. Z  Cell 
Biol. 98:1757-1762. 
31.  Rice, C., and J. Strauss.  198l. Nudeotide sequence of the 26S mRNA of Sindbis virus 
and deduced sequence of the encoded virus structural proteins.  Proc.  Natl.  Acad Sci. 
USA.  78:2062-2066. 
32.  Riedel,  H., C. Kondor-Koch, and H. Garoff. 1984. Cell surface expression  of fusogenic 
vesicular stomatitus virus G protein from cloned eDNA. EMBO (Eur. MoL Biol. Organ.) 
J. 3:1477-1483. 
33.  Skehel, J., P. Bayley, E. Brown, S. Martin, M. Watertleld,  J. White,  I. Wilson,  and D. 
Wiley.  1982. Changes in the conformation of influenza virus hemagglutinin at the pH 
optimum of virus-medicated membrane fusion.  Proc.  Natl.  Acad.  Sci.  USA.  79:968- 
972. 
34.  Tanasugarn, L.. P. McNeil, G. T. Reynolds, and D. L. Taylor. 1984. Microspectrofluo- 
rometry by digital  image processing:  measurement of cytoplasmic pH. J.  Cell Biol. 
98:717-724. 
35.  Tycko, B., and F. R. Maxfield.  1982. Rapid acidification  of  endocytie vesicles containing 
a2-maeroglobulin. Cell. 28:643-651. 
36.  V~ifio~inen, P., C. G. Gahmberg, and L. ~iinen.  1981. Fusion  of Semliki  Forest 
virus with red cell membranes. Virology.  110:366-374. 
37.  Walter, P., R. C. Jackson, M. M. Marcus, V. R. Lingappa, and G. Blobel. 1979. Tryptic 
dissection and recoostitution  of translocation  activity for nascent pre-secretory  proteins 
across mierosomal membranes. Proc. Natl. Acad.  Sci.  USA.  76:1795-1799. 
38.  Wang, K., and F. M. Richards.  1974. An approach to nearest neighbor analysis  of 
membrane proteins.  J. BioL  Chem. 249:8005-8018. 
39.  Welch, W. J., and B. M. Sefton. 1979. Two small virus-specific polypeptides are produced 
during infection  with Sindbis virus. J. ViroL 29:1186-1195. 
40.  White, J., and A. Helenius.  1980. pH-dependent fusion between the Semlild Forest virus 
membrane and liposornes. Proc. Natl.  Acad.  Sci.  USA.  77:3273-3277. 
41.  White,  J., J. Kartenbeck, and A. Helenius.  1980. Fusion of Semliki  Forest virus with 
the plasma membrane can be induced by low pH. J. CellBiol.  87:264--272. 
42.  White, J., A. Helenius,  and M. J. Gething, 1982. The haemagglutinio of influenza  virus 
expressed  from a cloned gene promotes membrane fusion.  Nature (Lond).  300:658- 
659. 
43.  White, J., M. Kielian,  and A. Helenius.  1983. Membrane fusion proteins of enveloped 
animal viruses. Q. Rev. Biophys.  16:151-195. 
44.  Wilson,  I., J. Skehel, and D. Wiley.  1981. Structure of the hemagglutinin membrane 
glycoprotein  of influenza virus at 3A resolution.  Nature (Lond.).  389:366-373. 
45. Ziemiecki, A., and H. Garoff. 1978. Subunit composition of  the membrane  glycoprotein 
complex of Semliki Forest virus. Z MoL Biol.  122:259-269. 
KIELIAN ANt9 HEtENIUS  Fusogenic  Spike Protein of Semliki Forest Virus  2291 